Reply
Reply
- Research Article
15
- 10.1016/j.jaci.2005.12.1306
- May 1, 2006
- Journal of Allergy and Clinical Immunology
Advances in upper airway diseases and allergen immunotherapy
- Research Article
110
- 10.1016/j.jaci.2013.07.009
- Aug 26, 2013
- Journal of Allergy and Clinical Immunology
National burden of antibiotic use for adult rhinosinusitis
- Research Article
1
- 10.1016/j.jaci.2012.01.050
- Feb 1, 2012
- The Journal of Allergy and Clinical Immunology
Advances in upper airway diseases and allergen immunotherapy in 2011
- Research Article
31
- 10.1016/j.jaci.2005.01.037
- Apr 1, 2005
- Journal of Allergy and Clinical Immunology
Advances in upper airway diseases and allergen immunotherapy
- Discussion
2
- 10.1016/j.jaci.2009.10.016
- Jan 12, 2010
- Journal of Allergy and Clinical Immunology
Reply
- Research Article
13
- 10.1016/j.jaip.2012.12.001
- Feb 6, 2013
- The Journal of Allergy and Clinical Immunology: In Practice
Chronic Rhinosinusitis
- Front Matter
1
- 10.1016/j.jaci.2022.07.002
- Jul 14, 2022
- The Journal of Allergy and Clinical Immunology
Chronic rhinosinusitis is associated with non–cystic fibrosis bronchiectasis: A new clinical implication?
- Front Matter
8
- 10.1016/j.jaci.2012.11.021
- Dec 22, 2012
- The Journal of Allergy and Clinical Immunology
Biologics and the treatment of chronic rhinosinusitis
- Front Matter
7
- 10.1016/j.jaci.2005.09.009
- Nov 8, 2005
- The Journal of Allergy and Clinical Immunology
Expanding the evidence base for the medical treatment of nasal polyposis
- Discussion
48
- 10.1016/j.jaci.2004.08.038
- Dec 1, 2004
- Journal of Allergy and Clinical Immunology
Transient postviral vocal cord dysfunction
- Research Article
26
- 10.1016/j.jaci.2020.02.010
- Feb 26, 2020
- Journal of Allergy and Clinical Immunology
Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes
- Discussion
1
- 10.1016/j.jaip.2017.08.018
- Nov 1, 2017
- The Journal of Allergy and Clinical Immunology: In Practice
Reply
- Discussion
2
- 10.1016/j.jaci.2011.08.039
- Oct 27, 2011
- Journal of Allergy and Clinical Immunology
Reply
- Front Matter
6
- 10.1016/j.jaci.2022.03.001
- Mar 15, 2022
- Journal of Allergy and Clinical Immunology
Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor?
- Front Matter
14
- 10.1016/j.jaci.2014.12.1907
- Feb 1, 2015
- Journal of Allergy and Clinical Immunology
Targeted therapy for allergic diseases: At the intersection of cutting-edge science and clinical practice
- Ask R Discovery
- Chat PDF
AI summaries and top papers from 250M+ research sources.